Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases

Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases

US Patent 11512127 · Granted Nov 29, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD123 binding proteins and related compositions and methods2025
Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Semiconductor device and manufacturing method thereof2025
Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor lig2025
Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor lig2025
Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor lig2025
Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor lig2025
Anti-IL-6 antibody2024
CD123 binding proteins and related compositions and methods2024
Antibodies and chimeric antigen receptors specific for ROR12024
Antibodies and chimeric antigen receptors specific for CD192023
Bi-specific antigen-binding polypeptides2023